Thus HUMT promotes tumor-induced lymphangiogenesis and lymphatic metastasis in TNBC by pathologically activating the VEGF-C signaling pathway via the FOXK1/HIF-1α axis [134]. The gene discussed is VEGFC; the disease is neoplasm.